Since diverse mechanisms have been characterized for activating latent TGFβ in RDEB [22], suppressing one latent TGFβ activator may not be sufficient to inhibit fibrosis globally, and the use of inhibitors targeting multiple latent TGFβ activators may need to be considered [75]. The gene discussed is TGFB1; the disease is recessive dystrophic epidermolysis bullosa.